BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet. 2004;364:803-811. [PMID: 15337409 DOI: 10.1016/s0140-6736(04)16942-0] [Cited by in Crossref: 268] [Cited by in F6Publishing: 105] [Article Influence: 15.8] [Reference Citation Analysis]
Number Citing Articles
1 Loring DW, Meador KJ, Shinnar S, Gaillard WD, Wheless JW, Kessler SK, Conry JA, Berl MM, Burns TG, Glauser TA, Kinkead B, Cnaan A. Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsy. Epilepsy Behav 2020;102:106687. [PMID: 31816478 DOI: 10.1016/j.yebeh.2019.106687] [Reference Citation Analysis]
2 Luo J, Eldredge C, Cho CC, Cisler RA. Population Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials Data. JMIR Med Inform 2016;4:e30. [PMID: 27751983 DOI: 10.2196/medinform.6437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
3 Gouldthorpe O, Catto-Smith AG, Alex G. Biologics in paediatric Crohn's disease. Gastroenterol Res Pract 2011;2011:287574. [PMID: 22144993 DOI: 10.1155/2011/287574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Hoffman TM, Taeed R, Niles JP, McMillin MA, Perkins LA, Feltes TF. Parental factors impacting the enrollment of children in cardiac critical care clinical trials. Pediatr Cardiol 2007;28:167-71. [PMID: 17505864 DOI: 10.1007/s00246-006-0020-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
5 Pontrelli G, Ciabattini M, De Crescenzo F, Biondi I, Cocchiola R, Copponi G, Frillici C, Molinari F, Rocchi F, Simonetti A, Rossi P, Livadiotti S. The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy. Ital J Pediatr 2021;47:156. [PMID: 34256815 DOI: 10.1186/s13052-021-01099-0] [Reference Citation Analysis]
6 Behrmann J. The paucity of ethical analysis in allergology. Allergy Asthma Clin Immunol 2013;9:5. [PMID: 23388345 DOI: 10.1186/1710-1492-9-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Graetz DE, Madni A, Gossett J, Kang G, Sabin JA, Santana VM, Russo CL. Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers. Cancer 2021;127:284-90. [PMID: 33119199 DOI: 10.1002/cncr.33268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Truog RD. Ethical assessment of pediatric research protocols. Intensive Care Med 2008;34:198-202. [PMID: 17982740 DOI: 10.1007/s00134-007-0917-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
9 Huntington C, Newton JT, Donaldson N, Liossi C, Reynolds PA, Alharatani R, Hosey MT. Lessons learned on recruitment and retention in hard-to-reach families in a phase III randomised controlled trial of preparatory information for children undergoing general anaesthesia. BMC Oral Health 2017;17:122. [PMID: 28882136 DOI: 10.1186/s12903-017-0411-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Greenberg RG, Corneli A, Bradley J, Farley J, Jafri HS, Lin L, Nambiar S, Noel GJ, Wheeler C, Tiernan R, Smith PB, Roberts J, Benjamin DK Jr. Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative. Contemp Clin Trials Commun 2018;9:7-12. [PMID: 29696219 DOI: 10.1016/j.conctc.2017.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 El Taguri A, Nasef A. The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19. Libyan J Med 2020;15:1770518. [PMID: 32459574 DOI: 10.1080/19932820.2020.1770518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Gentile S. Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders. Paediatr Drugs. 2011;13:291-302. [PMID: 21888443 DOI: 10.2165/11591250-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Franshaw L, Tsoli M, Byrne J, Mayoh C, Sivarajasingam S, Norris M, Marshall GM, Ziegler DS. Predictors of Success of Phase II Pediatric Oncology Clinical Trials. Oncologist 2019;24:e765-74. [PMID: 30808815 DOI: 10.1634/theoncologist.2017-0666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Brooks RJ, Higgins GY, Webster AC. Systematic review of randomized controlled trial quality in pediatric kidney transplantation. Pediatr Nephrol 2010;25:2383-92. [PMID: 20694479 DOI: 10.1007/s00467-010-1595-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
15 Mahony L, Sleeper LA, Anderson PA, Gersony WM, McCrindle BW, Minich LL, Newburger JW, Saul JP, Vetter VL, Pearson GD; Pediatric Heart Network Investigators. The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol 2006;27:191-8. [PMID: 16261271 DOI: 10.1007/s00246-005-1151-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
16 Volkening LK, Gaffney KC, Katz ML, Laffel LM. Recruitment Into a Pediatric Continuous Glucose Monitoring RCT. J Diabetes Sci Technol 2017;11:100-7. [PMID: 27340247 DOI: 10.1177/1932296816656208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Baan EJ, de Smet VA, Hoeve CE, Pacurariu AC, Sturkenboom MCJM, de Jongste JC, Janssens HM, Verhamme KMC. Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous Reports. Drug Saf 2020;43:7-16. [PMID: 31617080 DOI: 10.1007/s40264-019-00870-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wendler D. Is it possible to protect pediatric research subjects without blocking appropriate research? J Pediatr 2008;152:467-70. [PMID: 18346497 DOI: 10.1016/j.jpeds.2007.09.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
19 Livingston MH, Mahant S, Ratjen F, Connolly BL, Thorpe K, Mamdani M, Maclusky I, Laberge S, Giglia L, Walton JM, Yang CL, Roberts A, Shawyer AC, Brindle M, Parsons SJ, Stoian CA, Cohen E. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial. Trials 2017;18:293. [PMID: 28646887 DOI: 10.1186/s13063-017-2026-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
20 Brody JL, Turner CW, Annett RD, Scherer DG, Dalen J. Predicting adolescent asthma research participation decisions from a structural equations model of protocol factors. J Adolesc Health 2012;51:252-8. [PMID: 22921135 DOI: 10.1016/j.jadohealth.2011.12.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
21 Hall NJ, Sherratt FC, Eaton S, Reading I, Walker E, Chorozoglou M, Beasant L, Wood W, Stanton M, Corbett HJ, Rex D, Hutchings N, Dixon E, Grist S, Hoff WV, Crawley E, Blazeby J, Young B. Conservative treatment for uncomplicated appendicitis in children: the CONTRACT feasibility study, including feasibility RCT. Health Technol Assess 2021;25:1-192. [PMID: 33630732 DOI: 10.3310/hta25100] [Reference Citation Analysis]
22 Chan PY, Morris JM, Leslie GI, Kelly PJ, Gallery ED. The long-term effects of prematurity and intrauterine growth restriction on cardiovascular, renal, and metabolic function. Int J Pediatr 2010;2010:280402. [PMID: 21197428 DOI: 10.1155/2010/280402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
23 Waters KA, Chawla J, Harris MA, Dakin C, Heussler H, Black R, Cheng A, Burns H, Kennedy JD, Lushington K. Rationale for and design of the "POSTA" study: Evaluation of neurocognitive outcomes after immediate adenotonsillectomy compared to watchful waiting in preschool children. BMC Pediatr 2017;17:47. [PMID: 28152984 DOI: 10.1186/s12887-016-0758-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS. Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics 2012;130:e1269-77. [PMID: 23027172 DOI: 10.1542/peds.2011-3565] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
25 Groff ML, Offringa M, Emdin A, Mahood Q, Parkin PC, Cohen E. Publication Trends of Pediatric and Adult Randomized Controlled Trials in General Medical Journals, 2005-2018: A Citation Analysis. Children (Basel) 2020;7:E293. [PMID: 33333770 DOI: 10.3390/children7120293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Menson EN, Walker AS, Sharland M, Wells C, Tudor-Williams G, Riordan FA, Lyall EG, Gibb DM; Collaborative HIV Paediatric Study Steering Committee. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study. BMJ 2006;332:1183-7. [PMID: 16709991 DOI: 10.1136/bmj.332.7551.1183] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 4.7] [Reference Citation Analysis]
27 Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannidis JP, Mandl KD. Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics 2012;130:285-92. [PMID: 22826574 DOI: 10.1542/peds.2012-0139] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 8.2] [Reference Citation Analysis]
28 Maslen H, Earp BD, Cohen Kadosh R, Savulescu J. Brain stimulation for treatment and enhancement in children: an ethical analysis. Front Hum Neurosci 2014;8:953. [PMID: 25566011 DOI: 10.3389/fnhum.2014.00953] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
29 Giannuzzi V, Devlieger H, Margari L, Odlind VL, Ragab L, Bellettato CM, D'Avanzo F, Lampe C, Cassis L, Cortès-Saladelafont E, Cazorla ÁG, Barić I, Cvitanović-Šojat L, Fumić K, Dali CI, Bartoloni F, Bonifazi F, Scarpa M, Ceci A. The ethical framework for performing research with rare inherited neurometabolic disease patients. Eur J Pediatr 2017;176:395-405. [PMID: 28093642 DOI: 10.1007/s00431-017-2852-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Nikolakopoulos S, Roes KC, van der Lee JH, van der Tweel I. Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review. Trials 2014;15:274. [PMID: 25004909 DOI: 10.1186/1745-6215-15-274] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
31 Nicholl A, O'Sullivan TA. Keep Calm and Carry on: Parental Opinions on Improving Clinical Dietary Trials for Young Children. Nutrients 2018;10:E1166. [PMID: 30149614 DOI: 10.3390/nu10091166] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Sherratt FC, Beasant L, Crawley EM, Hall NJ, Young B. Enhancing communication, informed consent and recruitment in a paediatric urgent care surgical trial: a qualitative study. BMC Pediatr 2020;20:140. [PMID: 32228534 DOI: 10.1186/s12887-020-02040-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Halpern SD, Randolph AG, Angus DC. No child left behind: Enrolling children and adults simultaneously in critical care randomized trials. Crit Care Med 2009;37:2638-41. [PMID: 19602971 DOI: 10.1097/CCM.0b013e3181a59357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
34 Welch MJ, Lally R, Miller JE, Pittman S, Brodsky L, Caplan AL, Uhlenbrauck G, Louzao DM, Fischer JH, Wilfond B. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clin Trials 2015;12:503-10. [PMID: 26374681 DOI: 10.1177/1740774515597701] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
35 Torok RD, Li JS, Kannankeril PJ, Atz AM, Bishai R, Bolotin E, Breitenstein S, Chen C, Diacovo T, Feltes T, Furlong P, Hanna M, Graham EM, Hsu D, Ivy DD, Murphy D, Kammerman LA, Kearns G, Lawrence J, Lebeaut B, Li D, Male C, McCrindle B, Mugnier P, Newburger JW, Pearson GD, Peiris V, Percival L, Pina M, Portman R, Shaddy R, Stockbridge NL, Temple R, Hill KD. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc 2018;7:e007283. [PMID: 29440007 DOI: 10.1161/JAHA.117.007283] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
36 Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164:552-8. [PMID: 15912383 DOI: 10.1007/s00431-005-1698-8] [Cited by in Crossref: 222] [Cited by in F6Publishing: 153] [Article Influence: 13.9] [Reference Citation Analysis]
37 Russo C, Stout L, House T, Santana VM. Barriers and facilitators of clinical trial enrollment in a network of community-based pediatric oncology clinics. Pediatr Blood Cancer 2020;67:e28023. [PMID: 31556250 DOI: 10.1002/pbc.28023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
38 Lloyd J, McHugh C, Minton J, Eke H, Wyatt K. The impact of active stakeholder involvement on recruitment, retention and engagement of schools, children and their families in the cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP): a school-based intervention to prevent obesity. Trials 2017;18:378. [PMID: 28807006 DOI: 10.1186/s13063-017-2122-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Goldstein S. Clinical efficacy and safety of anticholinergic therapies in pediatric patients. Ther Clin Risk Manag 2019;15:437-49. [PMID: 30936706 DOI: 10.2147/TCRM.S161362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise JM, Santa J, Conway PH, Daudelin D, Morrato EH, Leslie LK. A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med 2012;27:985-91. [PMID: 22528615 DOI: 10.1007/s11606-012-2037-1] [Cited by in Crossref: 193] [Cited by in F6Publishing: 141] [Article Influence: 21.4] [Reference Citation Analysis]
41 Greenberg RG, Gamel B, Bloom D, Bradley J, Jafri HS, Hinton D, Nambiar S, Wheeler C, Tiernan R, Smith PB, Roberts J, Benjamin DK Jr. Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative. Contemp Clin Trials Commun 2018;9:33-9. [PMID: 29696222 DOI: 10.1016/j.conctc.2017.11.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
42 Stocks J, Lum S. Back to school: challenges and rewards of engaging young children in scientific research. Arch Dis Child 2016;101:785-7. [PMID: 27117837 DOI: 10.1136/archdischild-2015-310347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Lantos JD, Wendler D, Septimus E, Wahba S, Madigan R, Bliss G. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials. Clin Trials 2015;12:485-93. [PMID: 26374686 DOI: 10.1177/1740774515597687] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
44 Schoot RA, van Ommen CH, Caron HN, Tissing WJ, van de Wetering MD; SKION Aristocaths supportive care group the Netherlands. Accrual in supportive care trials in pediatric oncology, a challenge! Support Care Cancer 2012;20:3149-53. [PMID: 22476398 DOI: 10.1007/s00520-012-1447-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
45 Pike NA, Pemberton V, Allen K, Jacobs JP, Hsu DT, Lewis AB, Ghanayem N, Lambert L, Crawford K, Atz T, Korsin R, Xu M, Ravishankar C, Cnota J, Pearson GD. Challenges and successes of recruitment in the "angiotensin-converting enzyme inhibition in infants with single ventricle trial" of the Pediatric Heart Network. Cardiol Young 2013;23:248-57. [PMID: 22931751 DOI: 10.1017/S1047951112000832] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Araslanova R, Paradis J, Rotenberg BW. Publication trends in obstructive sleep apnea: Evidence of need for more evidence. World J Otorhinolaryngol Head Neck Surg 2017;3:72-8. [PMID: 29204582 DOI: 10.1016/j.wjorl.2017.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
47 Weijenberg A, Brouwer OF, Callenbach PM. Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review. CNS Drugs 2015;29:371-82. [PMID: 26013703 DOI: 10.1007/s40263-015-0248-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
48 Bredenoord A, Dondorp W, Pennings G, de Die-Smulders C, Smeets B, de Wert G. Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice. Eur J Hum Genet 2009;17:1550-9. [PMID: 19471315 DOI: 10.1038/ejhg.2009.88] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
49 Howard AF, Goddard K, Rassekh SR, Samargandi OA, Hasan H. Clinical significance in pediatric oncology randomized controlled treatment trials: a systematic review. Trials. 2018;19:539. [PMID: 30290839 DOI: 10.1186/s13063-018-2925-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Burns J, Ramchandren S, Ryan MM, Shy M, Ouvrier RA. Determinants of reduced health-related quality of life in pediatric inherited neuropathies. Neurology 2010;75:726-31. [PMID: 20733147 DOI: 10.1212/WNL.0b013e3181eee496] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
51 Hwang TJ, Kesselheim AS, Bourgeois FT. Postmarketing trials and pediatric device approvals. Pediatrics 2014;133:e1197-202. [PMID: 24733871 DOI: 10.1542/peds.2013-3348] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
52 Murthy S, Mandl KD, Bourgeois F. Analysis of pediatric clinical drug trials for neuropsychiatric conditions. Pediatrics 2013;131:1125-31. [PMID: 23650305 DOI: 10.1542/peds.2012-2694] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
53 Wendler DS. Assent in paediatric research: theoretical and practical considerations. J Med Ethics 2006;32:229-34. [PMID: 16574878 DOI: 10.1136/jme.2004.011114] [Cited by in Crossref: 88] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
54 Gruen ME, Jiamachello KN, Thomson A, Lascelles BD. Clinical trials involving cats: what factors affect owner participation? J Feline Med Surg 2014;16:727-35. [PMID: 24938313 DOI: 10.1177/1098612X14539499] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
55 Knellwolf AL, Bauzon S, Alberighi OD, Lutsar I, Bácsy E, Alfarez D, Panei P. Framework conditions facilitating paediatric clinical research. Ital J Pediatr 2011;37:12. [PMID: 21345195 DOI: 10.1186/1824-7288-37-12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
56 van der Lee JH, Tanck MW, Wesseling J, Offringa M. Pitfalls in the design and analysis of paediatric clinical trials: a case of a 'failed' multi-centre study, and potential solutions. Acta Paediatr 2009;98:385-91. [PMID: 18826493 DOI: 10.1111/j.1651-2227.2008.01048.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
57 Beasant L, Brigden A, Parslow RM, Apperley H, Keep T, Northam A, Wray C, King H, Langdon R, Mills N, Young B, Crawley E. Treatment preference and recruitment to pediatric RCTs: A systematic review. Contemp Clin Trials Commun 2019;14:100335. [PMID: 30949611 DOI: 10.1016/j.conctc.2019.100335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 da Silva RE, Amato AA, Sousa TDR, de Carvalho MR, Novaes MRCG. The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends. Eur J Clin Pharmacol 2018;74:1001-10. [DOI: 10.1007/s00228-018-2474-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
59 Ruperto N, Carozzino L, Jamone R, Freschi F, Picollo G, Zera M, Della Casa Alberighi O, Salvatori E, Del Vecchio A, Dionisio P, Martini A. A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians. Ital J Pediatr 2011;37:48. [PMID: 21958958 DOI: 10.1186/1824-7288-37-48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
60 . Ethical issues in health research in children. Paediatr Child Health 2008;13:707-20. [PMID: 19436527 DOI: 10.1093/pch/13.8.707] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
61 Cornfield DN. Shifting the Paradigm in Hemolytic Uremic Syndrome. Pediatrics 2016;137. [PMID: 26644489 DOI: 10.1542/peds.2015-3524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Wendler D, Abdoler E, Wiener L, Grady C. Views of adolescents and parents on pediatric research without the potential for clinical benefit. Pediatrics 2012;130:692-9. [PMID: 22966027 DOI: 10.1542/peds.2012-0068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
63 Arasu K, Chang CY, Wong SY, Ong SH, Yang WY, Chong MHZ, Mavinkurve M, Khoo EJ, Chinna K, Weaver CM, Chee WSS. Design and strategies used for recruitment and retention in a double blind randomized controlled trial investigating the effects of soluble corn fiber on bone indices in pre-adolescent children (PREBONE-Kids study) in Malaysia. Contemp Clin Trials Commun 2021;22:100801. [PMID: 34195468 DOI: 10.1016/j.conctc.2021.100801] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Zhong Y, Zhang X, Zhou L, Li L, Zhang T. Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008-2019. BMC Pediatr 2021;21:212. [PMID: 33931029 DOI: 10.1186/s12887-021-02658-4] [Reference Citation Analysis]
65 Close S, Smaldone A, Fennoy I, Reame N, Grey M. Using information technology and social networking for recruitment of research participants: experience from an exploratory study of pediatric Klinefelter syndrome. J Med Internet Res 2013;15:e48. [PMID: 23512442 DOI: 10.2196/jmir.2286] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 6.1] [Reference Citation Analysis]
66 Tafuri G, Trotta F, Leufkens HG, Martini N, Sagliocca L, Traversa G. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. Eur J Clin Pharmacol 2009;65:209-16. [PMID: 18797857 DOI: 10.1007/s00228-008-0560-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
67 Orito Y, Kakara M, Okada A, Nagai N. Model-based approach to sampling optimization in studies of antibacterial drugs for infants and young children. Clin Transl Sci 2021;14:1543-53. [PMID: 33742784 DOI: 10.1111/cts.13018] [Reference Citation Analysis]
68 Renfro LA, Ji L, Piao J, Onar-Thomas A, Kairalla JA, Alonzo TA. Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group. JCO Precis Oncol 2019;3:PO. [PMID: 32923863 DOI: 10.1200/PO.19.00060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Shilling V, Williamson PR, Hickey H, Sowden E, Beresford MW, Smyth RL, Young B. Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners. PLoS One 2011;6:e21604. [PMID: 21765898 DOI: 10.1371/journal.pone.0021604] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
70 Fletcher JT, Graf N, Scarman A, Saleh H, Alexander SI. Nephrotoxicity with cyclooxygenase 2 inhibitor use in children. Pediatr Nephrol 2006;21:1893-7. [PMID: 16955281 DOI: 10.1007/s00467-006-0252-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
71 Giannuzzi V, Conte R, Landi A, Ottomano SA, Bonifazi D, Baiardi P, Bonifazi F, Ceci A. Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen. Orphanet J Rare Dis 2017;12:64. [PMID: 28372595 DOI: 10.1186/s13023-017-0617-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
72 Pandolfini C, Bonati M. Children's presence in research. A review of online registers. Eur J Clin Pharmacol 2009;65:873-80. [PMID: 19590865 DOI: 10.1007/s00228-009-0687-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Brennan RC, Furman W, Mao S, Wu J, Turner DC, Stewart CF, Santana V, McGregor LM. Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors. Cancer Chemother Pharmacol 2014;74:1191-8. [PMID: 25257509 DOI: 10.1007/s00280-014-2593-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
74 Prichard DO, Hamilton Z, Savage T, Smyth M, Penner C, Lakhani A, Carroll MW, Al Sarkhy A, Lemberg DA, Enns R, Jamieson D, Jacobson K. Capsule Endoscopy Complements Magnetic Resonance Enterography and Endoscopy in Evaluating Small Bowel Crohn's Disease.J Can Assoc Gastroenterol. 2020;3:279-287. [PMID: 33241181 DOI: 10.1093/jcag/gwz028] [Reference Citation Analysis]
75 Morrow BM, Argent AC, Kling S. Informed consent in paediatric critical care research--a South African perspective. BMC Med Ethics 2015;16:62. [PMID: 26354389 DOI: 10.1186/s12910-015-0052-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
76 Lewis JD, Albenberg L, Lee D, Kratz M, Gottlieb K, Reinisch W. The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:181-91. [PMID: 28079619 DOI: 10.1097/MIB.0000000000001009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 7.7] [Reference Citation Analysis]
77 Van De Maele K, Devlieger R, Gies I. How to Maximize Children's Involvement in Non-therapeutic Research-Lessons Learnt From EFFECTOR. Front Pediatr 2020;8:47. [PMID: 32133332 DOI: 10.3389/fped.2020.00047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kohane IS. No small matter: qualitatively distinct challenges of pediatric genomic studies. Genome Med 2011;3:62. [PMID: 21961648 DOI: 10.1186/gm278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
79 Deja E, Peters MJ, Khan I, Mouncey PR, Agbeko R, Fenn B, Watkins J, Ramnarayan P, Tibby SM, Thorburn K, Tume LN, Rowan KM, Woolfall K. Establishing and augmenting views on the acceptability of a paediatric critical care randomised controlled trial (the FEVER trial): a mixed methods study. BMJ Open 2021;11:e041952. [PMID: 33692177 DOI: 10.1136/bmjopen-2020-041952] [Reference Citation Analysis]
80 Pandolfini C, Bonati M, Rossi V, Santoro E, Choonara I, Naylor C, Sammons H, Jacqz-Aigrain E, Zarrabian S, Arnau JM, Castel JM, Danés I, Fuentes I. The DEC-net European register of paediatric drug therapy trials: contents and context. Eur J Clin Pharmacol 2008;64:611-7. [PMID: 18351329 DOI: 10.1007/s00228-007-0458-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
81 Bwakura-Dangarembizi M, Musesengwa R, Nathoo KJ, Takaidza P, Mhute T, Vhembo T. Ethical and legal constraints to children's participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial. BMC Med Ethics 2012;13:17. [PMID: 22818109 DOI: 10.1186/1472-6939-13-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
82 Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 2008;5:e166. [PMID: 18700812 DOI: 10.1371/journal.pmed.0050166] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
83 Errington J, Malik G, Evans J, Baston J, Parry A, Price L, Johnstone H, Peters S, Oram V, Howe K, Whiteley E, Tunnacliffe J, Veal GJ. Investigating the Experiences of Childhood Cancer Patients and Parents Participating in Optional Nontherapeutic Clinical Research Studies in the UK. Pediatr Blood Cancer 2016;63:1193-7. [PMID: 26928983 DOI: 10.1002/pbc.25960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
84 Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med 2008;5:e172. [PMID: 18700813 DOI: 10.1371/journal.pmed.0050172] [Cited by in Crossref: 100] [Cited by in F6Publishing: 73] [Article Influence: 7.7] [Reference Citation Analysis]
85 Weijer C, Grimshaw JM, Taljaard M, Binik A, Boruch R, Brehaut JC, Donner A, Eccles MP, Gallo A, McRae AD, Saginur R, Zwarenstein M. Ethical issues posed by cluster randomized trials in health research. Trials 2011;12:100. [PMID: 21507237 DOI: 10.1186/1745-6215-12-100] [Cited by in Crossref: 81] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
86 Pemberton VL, Browning B, Webster A, Dean JM, Moler FW. Therapeutic hypothermia after pediatric cardiac arrest trials: the vanguard phase experience and implications for other trials. Pediatr Crit Care Med 2013;14:19-26. [PMID: 23295834 DOI: 10.1097/PCC.0b013e31825b860b] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
87 Buscariollo DL, Davidson MA, Black M, Russell WE, Rothman RL, Moore DJ. Factors that influence parental attitudes toward enrollment in type 1 diabetes trials. PLoS One 2012;7:e44341. [PMID: 22937171 DOI: 10.1371/journal.pone.0044341] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
88 Jeong S, Sohn M, Kim JH, Ko M, Seo HW, Song YK, Choi B, Han N, Na HS, Lee JG, Kim IW, Oh JM, Lee E. Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013. Trials 2017;18:288. [PMID: 28637515 DOI: 10.1186/s13063-017-2025-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
89 Locher C, Gaab J, Blease C, Inderbinen M, Kost L, Koechlin H. Placebos Are Part of the Solution, Not the Problem. An Exemplification of the Case of Antidepressants in Pediatric Chronic Pain Conditions. Front Psychiatry 2019;10:998. [PMID: 32038331 DOI: 10.3389/fpsyt.2019.00998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF, Burggraaf J. Stimulation programs for pediatric drug research--do children really benefit? Eur J Pediatr 2007;166:849-55. [PMID: 17225950 DOI: 10.1007/s00431-006-0381-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
91 Connolly MR, Chaudari JY, Yang X, Ward N, Kitt RA, Herrmann RS, Krane EJ, LeBel AA, Smith SM, Walco GA, Weisman SJ, Turk DC, Dworkin RH, Gewandter JS. Design and Reporting Characteristics of Clinical Trials of Select Chronic and Recurrent Pediatric Pain Conditions: An Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks Systematic Review. J Pain 2019;20:394-404. [PMID: 30219729 DOI: 10.1016/j.jpain.2018.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
92 Dunn AG, Mandl KD, Coiera E, Bourgeois FT. The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children. PLoS One 2013;8:e84951. [PMID: 24376857 DOI: 10.1371/journal.pone.0084951] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
93 Shakhnovich V, Hornik CP, Kearns GL, Weigel J, Abdel-Rahman SM. How to Conduct Clinical Trials in Children: A Tutorial. Clin Transl Sci 2019;12:218-30. [PMID: 30657253 DOI: 10.1111/cts.12615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
94 Deakin CT, Alexander IE, Kerridge I. Accepting risk in clinical research: is the gene therapy field becoming too risk-averse? Mol Ther 2009;17:1842-8. [PMID: 19773741 DOI: 10.1038/mt.2009.223] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
95 Balan S, Hassali MA, Mak VS. Awareness, knowledge and views of off-label prescribing in children: a systematic review. Br J Clin Pharmacol 2015;80:1269-80. [PMID: 26314841 DOI: 10.1111/bcp.12750] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
96 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Santamaría E, Estévez JA, Riba J, Izquierdo I, Valle M. Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children. PLoS One 2017;12:e0176091. [PMID: 28419164 DOI: 10.1371/journal.pone.0176091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
98 Gesualdo F, Daverio M, Palazzani L, Dimitriou D, Diez-Domingo J, Fons-Martinez J, Jackson S, Vignally P, Rizzo C, Tozzi AE. Digital tools in the informed consent process: a systematic review. BMC Med Ethics 2021;22:18. [PMID: 33639926 DOI: 10.1186/s12910-021-00585-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Strzebonska K, Wasylewski MT, Zaborowska L, Polak M, Slugocka E, Stras J, Blukacz M, Gyawali B, Waligora M. Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis. Target Oncol 2021;16:415-24. [PMID: 34110559 DOI: 10.1007/s11523-021-00822-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Thomson D, Hartling L, Cohen E, Vandermeer B, Tjosvold L, Klassen TP. Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006. PLoS One 2010;5:e13106. [PMID: 20927344 DOI: 10.1371/journal.pone.0013106] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
101 Vandermeer B, van der Tweel I, Jansen-van der Weide MC, Weinreich SS, Contopoulos-Ioannidis DG, Bassler D, Fernandes RM, Askie L, Saloojee H, Baiardi P, Ellenberg SS, van der Lee JH. Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluation. BMC Med Res Methodol 2018;18:7. [PMID: 29321002 DOI: 10.1186/s12874-017-0456-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Pemberton VL, Kaltman JR, Pearson GD. Children and clinical studies: the National Heart, Lung, and Blood Institute's new multimedia resource for pediatric research. J Am Coll Cardiol 2009;54:502-4. [PMID: 19643309 DOI: 10.1016/j.jacc.2009.04.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
103 Hamm MP, Scott SD, Klassen TP, Moher D, Hartling L. Do health care institutions value research? A mixed methods study of barriers and facilitators to methodological rigor in pediatric randomized trials. BMC Med Res Methodol 2012;12:158. [PMID: 23078589 DOI: 10.1186/1471-2288-12-158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
104 Menzies JC, Morris KP, Duncan HP, Marriott JF. Patient and public involvement in Paediatric Intensive Care research: considerations, challenges and facilitating factors. Res Involv Engagem 2016;2:32. [PMID: 29507766 DOI: 10.1186/s40900-016-0046-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
105 Joseph PD, Craig JC, Caldwell PH. Clinical trials in children. Br J Clin Pharmacol. 2015;79:357-369. [PMID: 24325152 DOI: 10.1111/bcp.12305] [Cited by in Crossref: 125] [Cited by in F6Publishing: 83] [Article Influence: 20.8] [Reference Citation Analysis]